Mylan Faces Suit Over Orapred ANDA
Shionogi Pharma Inc. and Cima Labs Inc. have filed a patent infringement suit over Mylan Inc.'s bid to introduce a generic version of anti-inflammatory Orapred ODT in various strengths....To view the full article, register now.
Already a subscriber? Click here to view full article